Mexico Pharmaceuticals Market Summary, Competitive Analysis and Forecast to 2027

Pharmaceuticals in Mexico industry profile provides top-line qualitative and quantitative summary information including: market size (value 2017-22, and forecast to 2027). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Key Highlights

The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare.
The Mexican pharmaceuticals market had total revenues of $25.5 billion in 2022, representing a compound annual growth rate (CAGR) of 7.8% between 2017 and 2022.
0
According to in-house research, in 2022, Mexico accounted for 5.1% of the Americas pharmaceuticals market. The growth in the pharmaceutical market is mainly due to an increase in pharmaceutical spending by the government. According to the most recent data available from the OECD, pharmaceutical spending in Mexico stood at 22.1% of total health spending in 2021.

Scope

Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the pharmaceuticals market in Mexico
Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in Mexico
Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance
Add weight to presentations and pitches by understanding the future growth prospects of the Mexico pharmaceuticals market with five year forecasts

Reasons to Buy

What was the size of the Mexico pharmaceuticals market by value in 2022?
What will be the size of the Mexico pharmaceuticals market in 2027?
What factors are affecting the strength of competition in the Mexico pharmaceuticals market?
How has the market performed over the last five years?
What are the main segments that make up Mexico's pharmaceuticals market?

1 Executive Summary

1.1. Market value
1.2. Market value forecast
1.3. Geography segmentation
1.4. Market rivalry
1.5. Competitive landscape

2 Market Overview

2.1. Market definition
2.2. Market analysis

3 Market Data

3.1. Market value

4 Market Segmentation

4.1. Geography segmentation

5 Market Outlook

5.1. Market value forecast

6 Five Forces Analysis

6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry

7 Competitive Landscape

7.1. Who are the leading players?
7.2. What strategies do leading players follow?
7.3. Are there any threats toward leading players?

8 Company Profiles

8.1. Sanofi SA
8.2. Genomma Lab Internacional SAB de CV
8.3. Pfizer Inc.

9 Macroeconomic Indicators

9.1. Country data

10 Appendix

10.1. Methodology
10.2. Industry associations
10.3. Related research
10.4. About the Publisher

List of Tables

Table 1: Mexico pharmaceuticals market value: $ billion, 2017-22
Table 2: Mexico pharmaceuticals market geography segmentation: $ billion, 2022
Table 3: Mexico pharmaceuticals market value forecast: $ billion, 2022-27
Table 4: Sanofi SA: key facts
Table 5: Sanofi SA: Annual Financial Ratios
Table 6: Sanofi SA: Key Employees
Table 7: Sanofi SA: Key Employees Continued
Table 8: Genomma Lab Internacional SAB de CV: key facts
Table 9: Genomma Lab Internacional SAB de CV: Annual Financial Ratios
Table 10: Genomma Lab Internacional SAB de CV: Key Employees
Table 11: Pfizer Inc.: key facts
Table 12: Pfizer Inc.: Annual Financial Ratios
Table 13: Pfizer Inc.: Key Employees
Table 14: Pfizer Inc.: Key Employees Continued
Table 15: Maypo Farmaceutics SA de CV: key facts
Table 16: Mexico size of population (million), 2018-22
Table 17: Mexico gdp (constant 2005 prices, $ billion), 2018-22
Table 18: Mexico gdp (current prices, $ billion), 2018-22
Table 19: Mexico inflation, 2018-22
Table 20: Mexico consumer price index (absolute), 2018-22
Table 21: Mexico exchange rate, 2018-22

List of Figures

Figure 1: Mexico pharmaceuticals market value: $ billion, 2017-22
Figure 2: Mexico pharmaceuticals market geography segmentation: % share, by value, 2022
Figure 3: Mexico pharmaceuticals market value forecast: $ billion, 2022-27
Figure 4: Forces driving competition in the pharmaceuticals market in Mexico, 2022
Figure 5: Drivers of buyer power in the pharmaceuticals market in Mexico, 2022
Figure 6: Drivers of supplier power in the pharmaceuticals market in Mexico, 2022
Figure 7: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Mexico, 2022
Figure 8: Factors influencing the threat of substitutes in the pharmaceuticals market in Mexico, 2022
Figure 9: Drivers of degree of rivalry in the pharmaceuticals market in Mexico, 2022

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

Sanofi SA
Genomma Lab Internacional SAB de CV
Pfizer Inc.

License	Format	Properties	Price
SINGLE USER LICENSE PDF	The product is a PDF.	This is a single user license, allowing one user access to the product.	€312EUR$350USD£271GBP
SITE LICENSE PDF	The product is a PDF.	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€468EUR$525USD£406GBP
ENTERPRISE LICENSE PDF	The product is a PDF.	This is an enterprise license, allowing all employees within your organization access to the product.	€624EUR$700USD£542GBP

Key Highlights

Scope

Reasons to Buy

Table of Contents

Companies Mentioned (Partial List)

Related Topics

Related Reports

Joint Venture Deals in Pharmaceuticals and Biotechnology 2016-2025

Consumer Health in Mexico

Omega 3 Prescription Drugs - Global Strategic Business Report

Pharmaceutical Drugs Market Opportunities and Strategies to 2033

Pharmaceutical Drugs Market Report 2025